Jade Mountain Acquisition, a blank check company targeting the healthcare and technology sectors, filed on Thursday with the SEC to raise up to $100 million.
The Taipei City, Taiwan-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. At the proposed deal size, Jade Mountain Acquisition would command a market value of $129 million.
The company is led by CEO and Chairman Moses Chen, who currently serves as Managing Director of Maxpro Ventures and previously served as Acting COO of SyneuRx International. The company plans to target the healthcare and technology sectors, as well as technologically advanced segments of the medical, biotechnology, digital, data and data science, industrial, and financial fields. It plans to focus on businesses with enterprise values between $200 million and $2 billion, initially prioritizing those in North America, Europe, and Asia.
Jade Mountain Acquisition was founded in 2021 and plans to list on the Nasdaq under the symbol JMACU. EF Hutton is the sole bookrunner on the deal.
